Unknown

Dataset Information

0

Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults.


ABSTRACT:

Background

Adjuvanted herpes zoster (HZ) subunit (HZ/su) vaccine is recommended for healthy adults aged ?50 years, yet vaccine efficacy is expected to wane over time. Age-sex specific cost-effectiveness analyses of HZ/su vaccine are warranted to inform decision-making on vaccine policy. We aimed to determine the optimal gender-specific age for cost-effective HZ/su vaccination in Hong Kong.

Methods

A Markov model was used to compare outcomes with and without HZ/su in healthy males and females at age 50-80 years. Model outcome measures were total cost, HZ cases, and HZ-associated quality-adjusted life-years (QALYs) loss. Incremental cost per QALY saved (ICER) by HZ/su was estimated for each age-sex group. Sensitivity analyses were performed to examine robustness of model results.

Results

HZ/su reduced incidence of HZ in both males and females aged 50-80 years and the numbers needed to vaccinate to avoid one HZ case were lowest at age 60 years for males (6.05) and females (5.50). The highest QALY-saved occurred in females (0.00396 QALYs) and males (0.00379 QALYs) who were vaccinated at 60 years old. The ICERs were lowest at age 60-70 years for both genders. Using 1× gross domestic product per capita of Hong Kong (USD46,153) as willingness-to-pay threshold, HZ/su vaccine was accepted to be cost-effective for all female and male age groups at vaccine cost = USD160, for female aged 50-79 years and male aged 54-74 years at vaccine cost = USD200, and for female aged 59-71 years at vaccine cost = USD240.

Conclusions

HZ/su vaccine is more likely to be cost-effective for males and females aged between 60-70 years than the extreme age groups (less than 60 years and older than 70 years) in Hong Kong. The age range for cost-effective acceptance of HZ/su vaccine appears to be broader in females than males given the same vaccine cost and willingness-to-pay threshold.

SUBMITTER: You JHS 

PROVIDER: S-EPMC6319773 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5838796 | biostudies-literature
| S-EPMC6602903 | biostudies-literature
| S-EPMC5853346 | biostudies-literature
| S-EPMC9169546 | biostudies-literature
| S-EPMC5264671 | biostudies-literature
| S-EPMC4186035 | biostudies-literature
| S-EPMC6282315 | biostudies-literature
| S-EPMC8825562 | biostudies-literature
| S-EPMC6130298 | biostudies-other
| S-EPMC4514415 | biostudies-literature